CME Financial Facts
Other: 21.8MInterest and other borrowing costs: -31.1M
See Full Income Statement
Total Liabilities and Shareholders' Equity: 63.25B
Total Assets: 63.25B
See Full Balance Sheet
CME Group Inc. (CME) Earnings
|
Expand Research on CME
| Next EPS Date | 10/21/26 | EPS Growth Rate | +10.4% |
|---|---|---|---|
| Average EPS % Beat Rate | +1.3% | Revenue Growth Rate | +13.3% |
| Average % Move 1-Wk after EPS | +3.4% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/26  |
Q326 | N/A | $2.96 | N/A | N/A | $1.7B | N/A | N/A | N/A | ||
| 7/22/26 | Q226 | $2.99 | $2.95 | +$0.04 | $1.71B | $1.72B | N/A |  | | Details | |
| 4/22/26 | Q126 | $3.36 | $3.31 | +$0.05 | $1.9B | $1.85B | N/A | | | Details | |
| 2/4/26 | Q425 | $2.77 | $2.75 | +$0.02 | $1.65B | $1.64B | N/A | | | Details | |
| 10/22/25 | Q325 | $2.68 | $2.64 | +$0.04 | $1.5B | $1.53B | N/A | | | Details | |
| 7/23/25 | Q225 | $2.96 | $2.93 | +$0.03 | $1.7B | $1.68B | N/A | | | Details | |
| 4/23/25 | Q125 | $2.80 | $2.68 | +$0.12 | $1.64B | $1.59B | N/A | | | Details | |
| 2/12/25 | Q424 | $2.52 | $2.48 | +$0.04 | $1.53B | $1.53B | N/A | | | Details |
